NervGen Pharma Corp. Strategic Asset Allocation Index
NervGen Pharma Corp. strategic asset allocation index. NervGen Pharma Corp. (NGEN) has a Strategic Asset Allocation Index of 0.0% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $3.48 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of NervGen Pharma Corp. to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of NervGen Pharma Corp. (2024–2025)
Strategic asset allocation index of NervGen Pharma Corp. from 2024 to 2025. This chart shows how NervGen Pharma Corp.'s Strategic Asset Allocation Index has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $3.48 Million USD. Check NervGen Pharma Corp. (NGEN) tangible net worth to evaluate the tangible quality of the company's equity base.
NervGen Pharma Corp. Strategic Asset Allocation Index by Year (2024–2025)
NervGen Pharma Corp. strategic asset allocation index by year from 2024 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for NervGen Pharma Corp. from 2024 to 2025, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see NGEN market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.0% | $0.00 | $- | $0.00 | $3.48 Million | ▼ -0.3 pp |
| 2024 | 0.3% | $8.37K | $- | $8.37K | $2.57 Million | — |